These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30361472)

  • 21. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
    Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
    JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst; 1997 Jul; 89(14):1015-26. PubMed ID: 9230883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
    Coldman A; Phillips N
    CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Do women receive enough information to make informed choices about breast cancer screening?].
    Hofmann B
    Tidsskr Nor Laegeforen; 2020 Feb; 140(3):. PubMed ID: 32105039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening.
    Domingo L; Romero A; Blanch J; Salas D; Sánchez M; Rodríguez-Arana A; Ferrer J; Ibáñez J; Vega A; Laso MS; Castells X; Sala M
    Cancer Epidemiol; 2013 Oct; 37(5):660-5. PubMed ID: 23962702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing and Understanding Reactance, Self-Exemption, Disbelief, Source Derogation and Information Conflict in Reaction to Overdiagnosis in Mammography Screening: Scale Development and Preliminary Validation.
    Scherer LD; Suresh K; Lewis CL; McCaffery KJ; Hersch J; Cappella JN; Morse B; Tate CE; Mosley BS; Schmiege S; Schapira MM
    Med Decis Making; 2023; 43(7-8):789-802. PubMed ID: 37705500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mammography screening: presentation of scientific evidence as a basis for communication with women].
    Mühlhauser I; Höldke B
    Z Arztl Fortbild Qualitatssich; 2000 Oct; 94(9):721-31. PubMed ID: 11127779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position.
    Helvie MA; Bevers TB
    J Natl Compr Canc Netw; 2018 Nov; 16(11):1398-1404. PubMed ID: 30442738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammography screening. Benefits, harms, and informed choice.
    Jørgensen KJ
    Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening mammography in older women: a review.
    Walter LC; Schonberg MA
    JAMA; 2014 Apr; 311(13):1336-47. PubMed ID: 24691609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.
    Sardanelli F; Aase HS; Álvarez M; Azavedo E; Baarslag HJ; Balleyguier C; Baltzer PA; Beslagic V; Bick U; Bogdanovic-Stojanovic D; Briediene R; Brkljacic B; Camps Herrero J; Colin C; Cornford E; Danes J; de Geer G; Esen G; Evans A; Fuchsjaeger MH; Gilbert FJ; Graf O; Hargaden G; Helbich TH; Heywang-Köbrunner SH; Ivanov V; Jónsson Á; Kuhl CK; Lisencu EC; Luczynska E; Mann RM; Marques JC; Martincich L; Mortier M; Müller-Schimpfle M; Ormandi K; Panizza P; Pediconi F; Pijnappel RM; Pinker K; Rissanen T; Rotaru N; Saguatti G; Sella T; Slobodníková J; Talk M; Taourel P; Trimboli RM; Vejborg I; Vourtsis A; Forrai G
    Eur Radiol; 2017 Jul; 27(7):2737-2743. PubMed ID: 27807699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards more effective online information support for mammography screening decisions.
    Martucci J; Schmidt H
    Prev Med; 2018 Jun; 111():423-428. PubMed ID: 29223791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How a deliberative approach includes women in the decisions of screening mammography: a citizens' jury feasibility study in Andalusia, Spain.
    Baena-Cañada JM; Luque-Ribelles V; Quílez-Cutillas A; Rosado-Varela P; Benítez-Rodríguez E; Márquez-Calderón S; Rivera-Bautista JM
    BMJ Open; 2018 May; 8(5):e019852. PubMed ID: 29730621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative risk of cancer detection in breast cancer screening by protocol strategy.
    Blanch J; Sala M; Román M; Ederra M; Salas D; Zubizarreta R; Sanchez M; Rué M; Castells X;
    Breast Cancer Res Treat; 2013 Apr; 138(3):869-77. PubMed ID: 23471648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of different information brochures on women's decision-making regarding mammography screening: study protocol for a randomized controlled questionnaire study.
    Gummersbach E; in der Schmitten J; Abholz HH; Wegscheider K; Pentzek M
    Trials; 2013 Oct; 14():319. PubMed ID: 24083811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
    Broeders M; Paci E
    Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decision-making about mammographic screening: pursuing informed choice.
    Hersch J; Jansen J; McCaffery K
    Climacteric; 2018 Jun; 21(3):209-213. PubMed ID: 29419315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer screening: an evidence-based update.
    Fuller MS; Lee CI; Elmore JG
    Med Clin North Am; 2015 May; 99(3):451-68. PubMed ID: 25841594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality-of-life effects of screening mammography in Norway.
    Zahl PH; Kalager M; Suhrke P; Nord E
    Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.